Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

SNSS $0.65 0.1439 +28.44%
CYTK $11.12 1.1700 +11.76%
SPHS $5.86 0.4600 +8.52%
BDSI $2.55 0.2000 +8.51%
NKTR $17.29 1.1900 +7.39%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

PVCT $0.29 -0.0200 -6.45%
TGTX $5.91 -0.4000 -6.34%
VSTM $1.40 -0.0800 -5.41%
GALE $0.44 -0.0254 -5.40%
NLNK $10.58 -0.5300 -4.77%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | Next > | Last >>

Peregrine Licenses Novel Exosome-Based Cancer Detection and Monitoring Technology from UT Southwestern Medical Center

(Peregrine) July 14, 2016 - Peregrine Pharmaceuticals, Inc. today announced that the company has entered into an exclusive licensing agreement with University of Texas (UT) Southwestern Medical Center for a novel exosome technology that has potential application as a simple blood test to detect or monitor cancer.
read corporate press release 



ASCO Announces the Fourteen Practices Participating in the 2016 Quality Training Program

(ASCO) July 14, 2016 - The American Society of Clinical Oncology (ASCO) announced today the 14 practices participating in the 2016 Quality Training Program. The program is designed to train oncology health care providers to investigate and implement data-driven quality improvement and manage clinical and administrative processes and outcomes.
read press release 



American Society of Hematology Holds Foundational Workshop on Genome Editing

(ASH) July 14, 2016 - ASH has brought together clinical and laboratory-based scientists, funders, and regulators to share cutting-edge research and tackle key scientific and clinical hurdles in genome editing at the ASH Workshop on Genome Editing, July 14-15 in Washington, DC.
read press release 



CMS Releases CY 2017 Medicare Proposed Payment Regulations

(ASH) July 14, 2016 - The Centers for Medicare and Medicaid Services (CMS) recently released the CY 2017 proposed Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (HOPPS) rules, which outline changes in the payment in the physician office and hospital outpatient settings respectively.
read article 



Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan

(Amgen) July 13, 2016 - Amgen and Daiichi Sankyo Company, Limited today announced the execution of an exclusive agreement to commercialize nine biosimilars in Japan. The deal includes several biosimilars in late-stage development, including biosimilars of adalimumab, bevacizumab and trastuzumab.
read corporate press release 



Virginia Cancer Specialists First in the World to Enroll Patient in Cutting-Edge Lung Cancer Clinical Trial

(The US Oncology Network) July 14, 2016 - Virginia Cancer Specialists (VCS), Virginia’s premier cancer care center with more than 40 years of providing service to patients battling cancer and blood diseases, is the first in the world to enroll a patient in a new advanced lung cancer clinical trial that may hold promise for patients with ALK-positive locally advanced or metastatic non-small cell lung cancer (ALK+ NSCLC).
read corporate press release 



Blood Clots and Cancer: UNC Professor Identifies Research Priorities for National Institutes of Health

(UNC Health Care) July 13, 2016 - Nigel Key, director of the UNC Hemophilia and Thrombosis Center, led a national initiative to prioritize research in studying the prevalence and mechanisms of venous thrombosis in cancer patients.
read press release 



Older Women in the United States Not Receiving Recommended Bone Density Testing before Starting Cancer Treatment, Study Finds

(NCCN) July 13, 2016 - A Medical College of Wisconsin study published in the July issue of JNCCN found that older women are not receiving recommended bone density assessment prior to adjuvant therapy with aromatase inhibitors, possibly making them more vulnerable to bone fracture and comorbidity as a result of injury.
read press release 



Are Cancer Drugs Working? 'Liquid Biopsy' May Tell

(WebMD/HealthDay News) July 13, 2016 - Researchers have developed a blood test that might allow doctors to know quickly whether a cancer drug is working.
read article 



Penn Preclinical Study Outlines Cardiovascular Side Effects of Breast Cancer Drug

(Penn Medicine) July 13, 2016 - A receptor protein that is the target of the breast cancer drug trastuzumab (Herceptin) is needed for proper heart blood-vessel development, reported researchers from the Perelman School of Medicine at the University of Pennsylvania.
read press release 



Diet Tops Exercise for Cutting Weight, Cancer Risk, New Study Shows

(Fred Hutch News Service) July 13, 2016 - Whether cutting pounds or cancer risk, the crunches in your salad trump the crunches in your workout, say scientists at Fred Hutchinson Cancer Research Center.
read article 



Nivolumab Cost-Effectiveness Improves By Selecting Non-Squamous NSCLC PD-L1+ Patients To Receive Treatment

(IASLC) July 12, 2016 - Nivolumab, a checkpoint inhibitor approved for all squamous and non-squamous non-small cell lung cancer patients in 2015, is not cost-effective when compared to treatment with docetaxel, chemotherapy medication.
read press release 



Study Finds First Evidence That PD-1 Antibody Could Help Men with Metastatic Prostate Cancer

(OHSU) July 13, 2016 - Restoring tumor-specific immunity is a treatment strategy that works well in melanoma and lung cancer patients. Now a new study out of the OHSU Knight Cancer Institute is reviving hope that the approach also may help men with life-threatening prostate cancer.
read press release 



Antipsychotic Drug Also Relieves Nausea From Cancer Chemotherapy

(Reuters Health) July 13, 2016 - Adding the cheap antipsychotic drug olanzapine to conventional anti-vomiting medicine can help prevent nausea in cancer patients, according to a new test of 380 volunteers.
read article 



Ipilimumab Shows Impressive Activity After HSCT Failure

(Medscape Medical News) July 13, 2016 - The immunotherapy ipilimumab (Yervoy, Bristol-Myers Squibb Company) showed impressive activity in patients with hematologic malignancies who experienced relapse after receiving a hematopoietic stem cell transplant (HSCT). These patients have limited treatment options and a poor prognosis.
read article (free registration required) 



Here Are Some Ways Cancer Can Thwart the New Immunotherapy Drugs

(Washington Post/To Your Health blog) July 13, 2016 - A new type of cancer drug designed to unleash the immune system is revolutionizing treatment for advanced melanoma, lung cancer and other malignancies.
read article (free registration required) 



UCLA Study Finds Why Some Cancers Stop Responding to Immunotherapy

(Reuters) July 13, 2016 - Researchers have for the first time identified mechanisms that enable advanced melanoma to become resistant to a new class of drugs, known as immunotherapies, which work by enlisting the body's own immune system to fight the disease.
read article 



Immunotherapy Benefits Relapsed Stem Cell Transplant Recipients

(Dana-Farber) July 13, 2016 - For many patients with advanced blood cancers, a stem-cell transplant can drive the disease into remission. However, about one-third of these patients experience a relapse and face a very poor prognosis.
read press release 



BREAKING: Slavitt Suggests MACRA Could Be Delayed

(Modern Healthcare) July 13, 2016 - CMS Acting Administrator Andy Slavitt told lawmakers Wednesday that the agency is considering delaying the start date for Medicare payment reform, which is set to go into effect Jan 1.
read article 



GE Aims For $1 Billion Cell Therapy 'Tools' Business With Swiss Deal

(Reuters) July 13, 2016 - General Electric's healthcare unit aims to build a $1 billion business offering vital manufacturing tools for a coming wave of cell therapies, helped by the acquisition of a Swiss firm that doubles its presence in the field.
read article 



Pfizer Shares Tick Up After FDA Approves Pneumonia Vaccine For Adult Use

(Nasdaq/Investing.com) July 12, 2016 - Pfizer Inc shares ticked up on Tuesday after the U.S. Food and Drug Administration (FDA) approved the major pharmaceutical company's pneumonia vaccine for an expanded age indication for adults ages 18 to 49.
read article 



Merck Shifts 300+ Jobs Away From Pa., N.J.

(Philadelphia Inquirer) July 12, 2016 - Merck Research Laboratories is shifting jobs from its old manufacturing centers in Pennsylvania and New Jersey towards hotter biomedical research areas around Boston and San Francisco.
read article 



Lower-cost Biotech Drug Gets Thumbs Up From FDA Panel

(Washington Post/Associated Press) July 12, 2016 - The second-biggest selling drug in the world could get some cheaper competition in the U.S., after a federal panel endorsed an alternative version of the pricey medication used to treat rheumatoid arthritis and other inflammatory diseases.
read article (free registration required) 



Study Shows Doctor Engagement Critical For Obama To Reach His Health Reform Goals

(Forbes) July 12, 2016 - It’s clear that doctors, not health systems, are central to driving the revolution in healthcare.
read article 



St. Elizabeth Takes Over NKY Practices of OHC; Creates Comprehensive Cancer Care Destination

(Northern Kentucky Tribune) July 12, 2016 - OHC (Oncology Hematology Care) has entered into an agreement to transition its Northern Kentucky practice (excluding Maysville) to St. Elizabeth Healthcare.
read article